Navigating Pharmaceutical Investment Strategies

This chapter explores how the pharmaceutical industry is adapting through strategic collaborations and effective portfolio management, particularly in the realm of R&D. It delves into investment methodologies, including market neutral investing and the importance of thematic approaches focused on medical innovation. Additionally, the discussion contrasts regulatory environments and investment attitudes between U.S. and European markets, highlighting the implications for drug approvals and investment strategies.